Chèrie Kaefring
Health Technology
Profile
Chèrie Kaefring worked as a Director of Clinical Operations at Sesen Bio, Inc.
Former positions of Chèrie Kaefring
| Companies | Position | End |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Chèrie Kaefring
